Agreed, Gerald needs to address this. This isn't s
Post# of 30028
Posted On: 11/12/2014 1:23:12 PM
Re: Daveludlow #10585
Agreed, Gerald needs to address this. This isn't some random post made by an investor on a message board. This is a statement by the lead analyst for our stock, someone who up until now was respected by shareholders and has supported the company.
Like others, I question his motives for making such an outlandish revenue estimate and for posting his ridiculous RS scenario when it is in direct opposition to the reassurances the CEO has made to shareholders numerous times.
I place no credibility on these predictions, but it has rattled some shareholders, and needs to be addressed by the company. I've emailed Gerald to request he address Jason's latest comments. I expect we'll hear something soon.
Like others, I question his motives for making such an outlandish revenue estimate and for posting his ridiculous RS scenario when it is in direct opposition to the reassurances the CEO has made to shareholders numerous times.
I place no credibility on these predictions, but it has rattled some shareholders, and needs to be addressed by the company. I've emailed Gerald to request he address Jason's latest comments. I expect we'll hear something soon.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼